Navigation Links
Saudi Arabia's KAUST and IIT, Bombay to Collaborate on Scientific Research
Date:9/2/2007

is likely to achieve on its own.

KAUST and IIT Bombay agreed to establish research projects or programs planned and executed by either organization individually or by both collectively. The principal areas of research and collaboration to be developed and supported include chemical and energy sciences and engineering, materials sciences and engineering, research in biosciences and the environment, and applied mathematics and computational sciences.

Both parties pledged their best efforts to collaborate on the design, construction and initial operation of research centers and laboratory facilities; to cooperate on research projects conducted by either ITT Bombay, KAUST, or both; to hold scientific and/or technical meetings on topics of mutual interest; to exchange personnel (scientific, technical and administrative staff) for varying periods of time; to make use of each respective organizations facilities and instruments to be defined precisely by contracts; to exchange information on research and engineering in energy sciences; and to undertake other cooperative activities as mutually agreed.

Both parties also agreed to consult with each other on graduate and other educational programs and curricula in engineering, science, the environment, and computational sciences at KAUST. Both parties will also collaborate on exchange of students, postdoctoral fellows and junior faculty for varying periods of time.


'/>"/>
Contact: Jeff Weintraub
media@kaust.edu.sa
202-828-8836
King Abdullah University of Science & Technology (KAUST)
Source:Eurekalert

Page: 1 2

Related biology news :

1. Scientists collaborate to assess health of global environment
2. UNC computer, marine scientists collaborate to predict flow of toxic waters from Katrina
3. Pacific Rim researchers to collaborate on distributed bioinformatics analysis of avian flu
4. Software Tool for Converting Scientific Text into a Database of Functional Relationships
5. Protein synthesis can be controlled by light, opening way for new scientific, medical applications
6. Funding and bureaucracy, not access to journals, are chief obstacles to scientific productivity
7. Scientific issues associated with carbon-neutral energy sources such as cellulosic ethanol
8. IBM Transforms the Art of Scientific Expeditions
9. Genetically engineered animals help in scientific research that may benefit children
10. Rutgers researchers scientifically link dancing ability to mate quality
11. Traditional Chinese medicine for diabetes has scientific backing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2008)... H. Jones, deputy executive director of the Intern...rgy Outlook 2008" Dec. 9 at Rice University,s Bake...ess such questions as: Is the world facing a suppl...nt? What type of post-Kyoto policy framework might...evels, and what impact might such a policy framewo...
(Date:12/3/2008)...what,s number one at the box office this week. The...kings of the body, filmed by scientists using grou... Australia, scientists at Sydney,s Centenary Insti...by a parasite and followed the infection as it beg...Wolfgang Weninger, head of the Immune Imaging prog...
(Date:12/3/2008)...AND, Ore. December 3, 2008. The first 5-year fores... lands is now available to the public: Oregon,s Fo...ory and Analysis Report. , Here are some key fin... about 30 million acres; about half of Oregon,s to...is being converted to other uses particularly near...
(Date:12/3/2008)...A, Mo. "FORE"...Though they may not help improve ...nge the way golfers think about the local country ...y of Missouri study. , "There are more than 17,0...ately 70 percent of that land is not used for play...iology in the MU College of Arts and Science. "The...
Breaking Biology News(10 mins):'World Energy Outlook' to be presented at Rice University Dec. 9 2Scientists film inner workings of the immune system 2Forest inventories in Oregon include more than trees 2Forest inventories in Oregon include more than trees 3Golf course: Playing fields, wildlife sanctuaries or both 2Poniard Announces Positive First Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory 2252 1Poniard Announces Positive First Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory 2252 2Poniard Announces Positive First Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory 2252 3Poniard Announces Positive First Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory 2252 4Data Confirm Avastin 28R 29 Helps Patients With Metastatic Colorectal Cancer Live Even Longer 2250 1Data Confirm Avastin 28R 29 Helps Patients With Metastatic Colorectal Cancer Live Even Longer 2250 2Data Confirm Avastin 28R 29 Helps Patients With Metastatic Colorectal Cancer Live Even Longer 2250 3New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer 2248 1New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer 2248 2New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer 2248 3New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer 2248 4New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer 2248 5New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer 2248 6NYP Weill Cornell physician scientists present latest cancer findings at ASCO meeting 20747 1NYP Weill Cornell physician scientists present latest cancer findings at ASCO meeting 20747 2NYP Weill Cornell physician scientists present latest cancer findings at ASCO meeting 20747 3NYP Weill Cornell physician scientists present latest cancer findings at ASCO meeting 20747 4
...chronic and progressive lung disorder from which m...he disease is characterized by the insidious onset... , Now, Selman and coworkers present in an artic...oS ONE on Wednesday 30th May, strong evidence indi...uration of symptoms before diagnosis and display a...
...rshed decision to propose listing the polar bear a...he Wildlife Conservation Society (WCS) is launchin...rrestrial predator, not by following the bears the... drastically shrink as a result of global warming....WCS will use both current and historical satellite...
...symptoms in people with Parkinson,s disease and ot...t the electrical signals of their diseased brains....ich have been approved by the Food and Drug Admini...,000 Americans, the mechanisms by which deep brain...ll understood. , Biomedical engineers at Duke U...
... Institutes of Health (NIH), researchers from Rens...ics-based virtual model that can simulate a patien...on with existing 3-D models, adding the fourth dim...uracy and effectiveness of radiation treatment for...or of nuclear and biomedical engineering, and Suvr...
Other Biology News:Extra-aggressive form of idiopathic pulmonary fibrosis identified 2Want to save polar bears? Follow the ice 2Want to save polar bears? Follow the ice 3How brain pacemakers erase diseased messages 2How brain pacemakers erase diseased messages 3'Virtual Patient' to simulate real-time organ motions for radiation therapy 2
(Date:12/4/2008)...ire-FirstCall/ -- NeoStem, Inc.,(NYSE Alternext U...ction,processing and long-term storage of adult ...ed that it has reached a major milestone in its cu... ever collection center for collection of,adult s... need in New York,City and has chosen Bruce Yaffe...
(Date:12/4/2008)... MedImmune today announced that,i...ts with chronic asthma to,determine the safety of...ibody,(MAb) that targets the interleukin-5 recept...ing the IL-5R pathway may lead to a targeted appro... continued study of this antibody. , "Asthm...
(Date:12/4/2008)...swire/ -- Azur Pharma Limited ("Azur") today,anno...ent with BioSante,Pharmaceuticals, Inc ("BioSante...strin(TM). Elestrin is a fast drying gel formulati...ent of moderate to severe vasomotor symptoms,asso...e U.S. Food and Drug,Administration ("FDA") in De...
(Date:12/4/2008)...New Trade Name Onrigin(TM) for Laromustine , ,.../ -- VION PHARMACEUTICALS, INC. (OTC Bulletin Boa...d to events in connection with the 50th American S... Center in San Francisco from December 6-9, 2008. ... The Company announced that it would present sur...
Breaking Biology Technology:NeoStem's New York City Adult Stem Cell Collection Center Has Opened and Begun Collections 2NeoStem's New York City Adult Stem Cell Collection Center Has Opened and Begun Collections 3NeoStem's New York City Adult Stem Cell Collection Center Has Opened and Begun Collections 4MedImmune Advances Asthma Program With Start of Phase 2 Clinical Trial for Antibody Targeting IL-5 Receptor 2MedImmune Advances Asthma Program With Start of Phase 2 Clinical Trial for Antibody Targeting IL-5 Receptor 3Azur Pharma Ltd. Enters Into Definitive Agreement With BioSante Pharmaceuticals Inc [nasdaq: BPAX], to Acquire U.S. Rights to Elestrin (TM) 2Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting 2Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting 3Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting 4
.... - GE Healthcare,s efforts to create an early ...Electric Co.,s pending acquisition of Abbott Lab... diagnostics business units, according to GE execu...entered into a definitive agreement for GE, the pa...aboratory diagnostics business units for $8.13 bil...
...s. - The Medical College of Wisconsin , in respo...ed research, has been awarded a five-year, $8.1 mi...diagnostic device to test for avian flu and the ma...ant, which was awarded by the National Institutes...iseases , will be used to develop a device that wo...
...os is founder and CEO of the Delphi Group, a Bosto...and strategy, and director of Perot Systems, Innov...is February to speak at the Fusion 2007 CEO-CIO S...hts into the ways business and information technol...fective. , , WTN: What,s the ideal situation for ...
... - With its first accelerator building fully comm...break ground this spring on a new, 50,000 square f...h will be built next to Third Wave Technologies, w...he MGE Innovation Center, the park,s business incu...ll range in size from 2,500 to 5,000 square feet, ...
Other Biology Technology:GE acquisition may boost "early" healthcare strategy 2Medical College lands $8.1M grant to detect bird flu, bioterror agents 2Innovation expert speaks on the business-IT balancing act 2Innovation expert speaks on the business-IT balancing act 3Innovation expert speaks on the business-IT balancing act 4Innovation expert speaks on the business-IT balancing act 5Research park to add accelerator suites 2
...er combines top performance with exquisite design....unparalleled temperature uniformity. The instrumen...g in a spreadsheet or alternatively in a graphical... push of a button and swings in a defined end posi...
...d to be a solid, heavy-duty durable orbital shaker...nd vortexing in nature. The VSOS-4 Orbital Shak...orm orbital shaking motion (19mm circular) for a w...tissue culture, hybridization, staining and destai...
Preparation TW--Compatibility: no end cap seals -Hybridization Tube for Hybrigene -Comp Dim: 240 80 mm -Material: borosilicate glass -Mfr Desig: Techne FHB-15
...are designed for the rapid purification of linear ...d is excised from an,agarose gel and loaded into t...lumn are a series of membranes and filters that ho...to selectively pass through the column into a coll...
Biology Products: